Clinical Trials Browser

Phase 3 × Neoplasms × motesanib diphosphate × Clear all

NCT00460317 2015-09-07

MONET1-MOtesanib NSCLC Efficacy and Tolerability Study

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasms